{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:24:58Z","timestamp":1790414698312,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T00:00:00Z","timestamp":1128470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00296-005-0029-8","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T16:11:07Z","timestamp":1128442267000},"page":"545-550","source":"Crossref","is-referenced-by-count":53,"title":["Serum interleukin-18 levels in patients with Beh\u00e7et\u2019s disease. Is its expression associated with disease activity or clinical presentations?"],"prefix":"10.1007","volume":"26","author":[{"given":"U.","family":"Musabak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,10,5]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ard.61.suppl_2.ii100","volume":"61","author":"FY Liew","year":"2002","unstructured":"Liew FY, McInnes IB (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61:100\u2013102","journal-title":"Ann Rheum Dis"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.62.suppl_2.ii48","volume":"62","author":"FY Liew","year":"2003","unstructured":"Liew FY, Wei XQ, McInnes IB (2003) Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis 62:48\u201350","journal-title":"Ann Rheum Dis"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B","volume":"44","author":"M Yamamura","year":"2001","unstructured":"Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H (2001) Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 44:275\u2013285","journal-title":"Arthritis Rheum"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423\u2013474","journal-title":"Annu Rev Immunol"},{"issue":"suppl27","key":"29_CR5","first-page":"S1","volume":"20","author":"CA Dinerallo","year":"2002","unstructured":"Dinerallo CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20(suppl27):S1\u2013S13","journal-title":"Clin Exp Rheumatol"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","volume":"73","author":"JA Gracie","year":"2003","unstructured":"Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. J Leukoc Biol 73: 213\u2013224","journal-title":"J Leukoc Biol"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1517\/14728222.7.6.701","volume":"7","author":"K Matsui","year":"2003","unstructured":"Matsui K, Tsutsui H, Nakanishi K (2003) Pathophysiological roles for IL-18 in inflammatory arthritis. Expert Opin Ther Targets 7:701\u2013724","journal-title":"Expert Opin Ther Targets"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.4049\/jimmunol.167.5.2879","volume":"167","author":"BP Leung","year":"2001","unstructured":"Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, Cunha F, Liew FY, McInnes IB (2001) A role for IL-18 in neutrophil activation. J Immunol 167: 2879\u20132886","journal-title":"J Immunol"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","volume":"48","author":"LA Joosten","year":"2003","unstructured":"Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB (2003) Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 48:339\u2013347","journal-title":"Arthritis Rheum"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/art.20064","volume":"50","author":"SM Dai","year":"2004","unstructured":"Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K (2004) Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum 50:432\u2013443","journal-title":"Arthritis Rheum"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/labinvest.3780351","volume":"81","author":"JC Morel","year":"2001","unstructured":"Morel JC, Park CC, Kumar P, Koch AE (2001) Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest 81:1371\u20131383","journal-title":"Lab Invest"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4049\/jimmunol.170.2.1084","volume":"170","author":"M Komai-Koma","year":"2003","unstructured":"Komai-Koma M, Gracie JA, Wei XQ, Xu D, Thomson N, McInnes IB, Liew FY (2003) Chemoattraction of human T cells by IL-18. J Immunol 170:1084\u20131090","journal-title":"J Immunol"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","volume":"167","author":"CC Park","year":"2001","unstructured":"Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167:1644\u20131653","journal-title":"J Immunol"},{"issue":"Suppl1","key":"29_CR14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00002371-200203001-00009","volume":"25","author":"H Futani","year":"2002","unstructured":"Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, Nakanishi K, Tateishi H, Maruo S, Okamura H (2002) Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 25(Suppl1):S61\u2013S64","journal-title":"J Immunother"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1365-2141.2000.02095.x","volume":"109","author":"Y Fujimori","year":"2000","unstructured":"Fujimori Y, Takatsuka H, Takemoto Y, Hara H, Okamura H, Nakanishi K, Kakishita E (2000) Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 109:652\u2013657","journal-title":"Br J Haematol"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease. Arthritis Rheum 44:550\u2013560","journal-title":"Arthritis Rheum"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC (2004) Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease. Ann Rheum Dis 63:1300\u20131306","journal-title":"Ann Rheum Dis"},{"key":"29_CR18","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) Uber rezidivierende apthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152\u20131157","journal-title":"Dermatol Wochenschr"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","volume":"42","author":"MA Frassanito","year":"1999","unstructured":"Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behcet\u2019s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42:1967\u20131974","journal-title":"Arthritis Rheum"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1998.tb02372.x","volume":"25","author":"E Alpsoy","year":"1998","unstructured":"Alpsoy E, Cayirli C, Er H, Yilmaz E (1998) The levels of plasma interleukin-2 and soluble interleukin-2R in Behcet\u2019s disease: a marker of disease activity. J Dermatol 25:513\u2013516","journal-title":"J Dermatol"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31:205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/IAI.36.1.202-208.1982","volume":"36","author":"S Ohno","year":"1982","unstructured":"Ohno S, Kato F, Matsuda H, Fujii N, Minagawa T (1982) Detection of gamma interferon in the sera of patients with Behcet\u2019s disease. Infect Immun 36:202\u2013208","journal-title":"Infect Immun"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000309241","volume":"185","author":"S Ohno","year":"1982","unstructured":"Ohno S, Kato F, Matsuda H, Fujii N, Minagawa T (1982) Studies on spontaneous production of gamma-interferon in Behcet\u2019s disease. Ophthalmologica 185:187\u2013192","journal-title":"Ophthalmologica"},{"key":"29_CR24","first-page":"541","volume":"57","author":"TH Bacon","year":"1984","unstructured":"Bacon TH, Ozbakir F, Elms CA, Denman AM (1984) Interferon-gamma production by peripheral blood mononuclear cells from patients with Behcet\u2019s syndrome. Clin Exp Immunol 57:541\u2013547","journal-title":"Clin Exp Immunol"},{"key":"29_CR25","first-page":"996","volume":"39","author":"N Sugi-Ikai","year":"1998","unstructured":"Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M (1998) Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behcet\u2019s disease. Invest Ophthalmol Vis Sci 39:996\u20131004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"29_CR26","first-page":"329","volume":"25","author":"S Raziuddin","year":"1998","unstructured":"Raziuddin S, al-Dalaan A, Bahabri S, Siraj AK, al-Sedairy S (1998) Divergent cytokine production profile in Behcet\u2019s disease. Altered Th1\/Th2 cell cytokine pattern. J Rheumatol 25:329\u2013333","journal-title":"J Rheumatol"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","volume":"30","author":"BC Aridogan","year":"2003","unstructured":"Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S (2003) Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet\u2019s disease. J Dermatol 30:602\u2013607","journal-title":"J Dermatol"},{"key":"29_CR28","first-page":"321","volume":"23","author":"N Sayinalp","year":"1996","unstructured":"Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S (1996) Cytokines in Behcet\u2019s disease. J Rheumatol 23:321\u2013322","journal-title":"J Rheumatol"},{"key":"29_CR29","first-page":"1428","volume":"17","author":"K Hamzaoui","year":"1990","unstructured":"Hamzaoui K, Hamza M, Ayed K (1990) Production of TNF-alpha and IL-1 in active Behcet\u2019s disease. J Rheumatol 17:1428\u20131429","journal-title":"J Rheumatol"},{"key":"29_CR30","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet\u2019s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544\u20131549","journal-title":"J Rheumatol"},{"issue":"Suppl30","key":"29_CR31","first-page":"S8","volume":"21","author":"A Hamzaoui","year":"2003","unstructured":"Hamzaoui A, Ghrairi H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behcet\u2019s disease. Clin Exp Rheumatol 21(Suppl30):S8\u2013S14","journal-title":"Clin Exp Rheumatol"},{"key":"29_CR32","first-page":"1078","volume":"335","author":"Disease InternationalStudyGroupfor Behcet\u2019s","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 38:728\u2013733","journal-title":"Rheumatology (Oxford)"},{"key":"29_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2230.2004.01684.x","volume":"30","author":"MO Oztas","year":"2005","unstructured":"Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet\u2019s disease. Clin Exp Dermatol 30:61\u201363","journal-title":"Clin Exp Dermatol"},{"key":"29_CR35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","volume":"42","author":"J Karasneh","year":"2003","unstructured":"Karasneh J, Hajeer AH, Barrett J, Ollier WE, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet\u2019s disease. Rheumatolgy 42:860\u2013864","journal-title":"Rheumatolgy"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0029-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-005-0029-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-005-0029-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T17:29:51Z","timestamp":1736011791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-005-0029-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,5]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s00296-005-0029-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,5]]}}}